ROHAN, Tomáš, Tomáš ANDRAŠINA, Jiří PÁNEK and Vlastimil VÁLEK. Percutaneus endoluminal forceps biopsy in cholangiocelular carcinoma: cost effectiveness analysis. In ECR 2018. 2018. Available from: https://dx.doi.org/10.1594/ecr2018/C-3232.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Percutaneus endoluminal forceps biopsy in cholangiocelular carcinoma: cost effectiveness analysis
Authors ROHAN, Tomáš (203 Czech Republic, guarantor, belonging to the institution), Tomáš ANDRAŠINA (703 Slovakia, belonging to the institution), Jiří PÁNEK (203 Czech Republic, belonging to the institution) and Vlastimil VÁLEK (203 Czech Republic, belonging to the institution).
Edition ECR 2018, 2018.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30224 Radiology, nuclear medicine and medical imaging
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
RIV identification code RIV/00216224:14110/18:00105915
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1594/ecr2018/C-3232
Keywords in English endluminal forceps biopsy; cost analysis; cholagniocellular carcinoma
Tags International impact
Changed by Changed by: MUDr. Tomáš Rohan, Ph.D., učo 358905. Changed: 1/6/2021 12:30.
Abstract
Analysis of percutaneous endoluminal forceps biopsy performed during initial drainage or as a postponed procedure.
Links
MUNI/A/1255/2017, interní kód MUName: Onkologické radiologické intervence a jejich přínos v rámci komplexní onkologické léčby, srovnání s celorepublikovými výsledky onkologické léčby vybraných diagnóz
Investor: Masaryk University, Category A
PrintDisplayed: 24/7/2024 00:25